Skip Navigation
Skip to contents

KDDW 2018

d-Day
D1991

  • Advancing Gastroenterology and Hepatology through Creative Integration
  • Abstract Submission and Registration are available via APDW 2018 website (www.apdw2018.org)

Program Details

Home    >    Scientific Program    >    Program Details
Symposium GI-01 (Motility)
Nov. 16 (Fri)
08:30-10:00
Updates in gastrointestinal neurogastro-motility disorders 105 (1F)
Chairperson(s) Nicholas J Talley (Newcastle), Kwang Jae Lee (Suwon)
08:30-08:50 Approach to esophageal disorders John Pandolfino
(Wilmette)
08:50-09:10 Approach to gastric disorders Nicholas J Talley
(Newcastle)
09:10-09:30 Approach to bowel disorders Eamonn Quigley
(Houston)
09:30-09:50 Differences of guidelines between Asia and West Jung-Ho Park
(Seoul)
09:50-10:00 Q&As
Free Paper (GI Cancer 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (GI Cancer 01) E4 (3F)
Chairperson(s) Jin Tae Jung (Daegu), Su Youn Nam (Daegu)
08:30-08:40 Effects of a 12 week home-based exercise program in patients with high risk of gastric cancer: A pilot study Jeung Eun Lee
(Seoul)
08:40-08:50 Subepithelial spread of early gastric signet ring cell carcinoma: How far they can reach? Sun Hyung Kang
(Daejeon)
08:50-09:00 Gastric cancer with lymph node metastasis more than 15 (N3b): is it really stage III disease? Sa-Hong Kim
(Seoul)
09:00-09:10 Predictive factors of lymph node metastasis in early gastric cancer patients with Seiwert type II/III Min Young Son
(Busan)
09:10-09:20 Abdominal computed tomography compared with endoscopic ultrasound sonography for the diagnosis of gastric subepithelial tumors Cheal Wung Huh
(Incheon)
Chairperson(s) Eun Kwang Choi (Jeju), Seung-Ok Lee (Jeonju)
09:30-09:40 Incidence and prognosis of subsequent cholangiocarcinoma in patients with hepatic resection for bile duct stones Seon Mee Park
(Cheongju)
09:40-09:50 Validation of the 8th edition of the American Joint Commission on Cancer (AJCC) staging system for pancreatic adenocarcinoma: Using Korean pancreatic cancer (K-PAC) registry Dong Woo Shin
(Seongnam)
09:50-10:00 Clinicopathologic characteristics of Intraductal Papillary Neoplasm of Bile duct (IPNB) after central review: Korean multi-center collaboration study Jae Ri Kim
(Seoul)
10:00-10:10 Adjuvant gemcitabine-based chemotherapy vs concurrent chemoradiotherapy after R0 resection for pancreatic ductal adenocarcinoma: A propensity score-matched analysis Min Su You
(Seoul)
Free Paper (LG 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (LG 01) E5 (3F)
Chairperson(s) Kyu Chan Huh (Daejeon), Sung-Ae Jung (Seoul)
08:30-08:40 A trial for the administration of a functionally enhanced tonsil-derived mesenchymal stem cells in a chronic colitis model. Yang Hee Joo
(Seoul)
08:40-08:50 The ability of epithelial regeneration is reduced in the Crohn's disease patient-derived organoids, especially in TNF-alpha enriched condition. Sung Noh Hong
(Seoul)
08:50-09:00 Diagnostic role of NOD signaling and apoptosis tests in patients with XIAP-deficient IBD Seak Hee Oh
(Seoul)
09:00-09:10 Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers Soo-Kyung Park
(Seoul)
09:10-09:20 Identification of prominent hub genes of colorectal cancer : Using network analysis of gene expression data Seong Ji Choi
(Seoul)
Chairperson(s) Byong Duk Ye (Seoul), Geom Seog Seo (Iksan)
09:20-09:30 Vegetarianism as a protective factor for asymptomatic colonic diverticulosis; A cross-sectional, case-control study between Buddhist priests and general population Jihun Bong
(Goyang)
09:30-09:40 Clinical outcome after endoscopic decompression of sigmoid volvulus; A multicenter-retrospective study, Daejeon-Chungchung intestinal research group Hee Seok Moon
(Daejeon)
09:40-09:50 Identification and validation of a peptide probe binding specifically to colon cancer cells Younghee Choe
(Seoul)
Free Paper (LG 2) (Korean & English)
Nov. 16 (Fri)
10:20-11:10
KDDW Free Paper (LG 02) E5 (3F)
Chairperson(s) Jin-Oh Kim (Seoul), Chang Hwan Choi (Seoul)
10:20-10:30 Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin Kyung Mo Yoo
(Seoul)
10:30-10:40 Clinicopathological features of malignant tumors of small bowel diagnosed by video capsule endoscopy and balloon-assisted enteroscopy: A single center experience Sunghee Kam
(Seoul)
10:40-10:50 Modifiable lifestyle risk factors and the risk of colorectal neoplasia recurrence Kyungjin Ko
(Seoul)
10:50-11:00 Differences in the clinicopathologic characteristics between right- and left-sided colon cancer Hannah Ra
(Incheon)
11:00-11:10 Epidemiology of colorectal cancer in Northern Malaysia: A 7-year review (2008-2014) Mohamad Fadli Abd Rahman
(Alor Setar)
Free Paper (GI Cancer 2) (Korean & English)
Nov. 16 (Fri)
10:30-12:00
KDDW Free Paper (GI Cancer 02) E4 (3F)
Chairperson(s) Yun Jeong Lim (Goyang), Bora Keum (Seoul)
10:30-10:40 Changing trends of colonoscopic burden: A nationwide population-based study in Korea Jae Myung Cha
(Seoul)
10:40-10:50 Risk of developing colorectal cancer based on the prior screening behaviors: Population-based cohort study. Su Young Kim
(Wonju)
10:50-11:00 Colorectal cancer screening among cancer survivors in the US Adeyinka O Laiyemo
(Washington)
11:00-11:10 Metabolically healthy obesity is associated with an increased risk of colorectal neoplasia recurrence Hyun Beom Chae
(Seoul)
11:10-11:20 Association between low relative muscle mass and the risk of colorectal neoplasia recurrence in Korean men and women Kyung Mo Yoo
(Seoul)
Chairperson(s) Jin-Hyeok Hwang (Seongnam), Jae Hee Cho (Incheon)
11:20-11:30 Neoadjuvant FOLFIRINOX in patients with locally advanced pancreatic cancer Young Hoon Choi
(Seoul)
11:30-11:40 Lymphocyte-to-monocyte ratio is a valuable marker for predicting survival in patients with gallbladder cancer undergoing chemotherapy compared to neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio Young Hoon Choi
(Seoul)
11:40-11:50 Clinicopathologic characteristics and kras molecular alterations of adenosquamous carcinoma of the pancreas compared to pancreatic ductal adenocarcinoma Sun Mi Lee
(Jeju)
11:50-12:00 Detection of circulating tumor DNA and its application in pancreatic cancer patients Joo Kyung Park
(Seoul)
Topic Forum (LG) (Korean)
Nov. 16 (Fri)
11:10-12:00
Topic Forum (LG) E5 (3F)
Chairperson(s) Hiun Suk Chae (Uijeongbu), Young-Eun Joo (Gwangju)
11:10-11:20 Risk factors including fecal markers for hospitalization in patients with ulcerative colitis Byung Jin Kwon
(Yangsan)
11:20-11:30 Mucosal healing is associated with transmural healing after 1-year treatment with anti-TNF agents in pediatric Crohn's disease patients Ben Kang
(Daegu)
11:30-11:40 Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on adalimumab maintenance therapy Eun Hye Oh
(Seoul)
11:40-12:00 Keynote Lecuture: Evolving monitoring for IBD patient care in clinical practice Byung Ik Jang
(Daegu)
Symposium GI-02 (UG)
Nov. 16 (Fri)
14:00-15:30
Gastric carcinogenesis: Host, microbiome, and their interactions 101 (1F)
Chairperson(s) Kwong Ming Fock (Singapore), Ki Baik Hahm (Seongnam)
14:00-14:20 Identification of genetic susceptibility for gastric cancer through genome-wide association studies Benjamin Wong
(Hong Kong)
14:20-14:40 Non-coding RNA and gastric cancer Sang Kil Lee
(Seoul)
14:40-15:00 Interactions between human and Helicobacter pylori in gastric carcinogenesis Richard Peek
(Nashville)
15:00-15:20 Non-Helicobacter pylori microbiome in gastric carcinogenesis Yoshio Yamaoka
(Yufu)
15:20-15:30 Q&As
Symposium GI-03 (LG)
Nov. 16 (Fri)
14:00-15:30
Shifting paradigm in IBD management 202 (2F)
Chairperson(s) Joo Sung Kim (Seoul), Siew Chien Ng (Hong Kong)
14:00-14:20 New drugs on the horizon: Targeting cytokines, cell trafficking, and more Choon Jin Ooi
(Singapore)
14:20-14:40 Fecal microbiota transplantation for IBD: Ready to use? Siew Chien Ng
(Hong Kong)
14:40-15:00 Toward improving quality of care in IBD management David Todd Rubin
(Chicago)
15:00-15:20 Things you should know when managing elderly IBD patients Jae Hee Cheon
(Seoul)
15:20-15:30 Q&As
Symposium GI-04 (GI Cancer)
Nov. 16 (Fri)
14:00-15:30
Gastirc cancer, are we in new era for management? E1+2 (3F)
Chairperson(s) Hyunyong Jeong (Daejeon), James R. Goldenring (Nashville)
14:00-14:20 The global change in epidemiology of gastric cancer Jin Young Park
(Lyon)
14:20-14:40 Role of?SPEM in gastric carcinogenesis James R. Goldenring
(Nashville)
14:40-15:00 Do we have proper surgical modalities to preserve functional aspect after gastric cancer surgery? Keun Won Ryu
(Goyang)
15:00-15:20 Current treatment landscape and future perspectives in patients with advanced gastric cancer Sung Eun Kim
(Busan)
15:20-15:30 Q&As
KDDW Free Paper (LG 3) (Korean)
Nov. 16 (Fri)
14:00-15:30
KDDW Free Paper (LG 3) E5 (3F)
Chairperson(s) Kooklae Lee (Seoul), Soon Man Yoon (Cheongju)
14:00-14:10 Cost drivers for inflammatory bowel disease care: a population-based study using the korean national health insurance claims data (2006-2015) Jung-Wook Kim
(Seoul)
14:10-14:20 Real life effectiveness and safety of vedolizumab as induction therapy for Korean IBD patients in whom anti-TNF treatment failed: A prospective cohort study Jeongseok Kim
(Seoul)
14:20-14:30 Influence of Vitamin D status on the clinical course of ulcerative colitis Nam Seok Ham
(Seoul)
Chairperson(s) Moon Sung Lee (Bucheon), Bo-In Lee (Seoul)
14:30-14:40 Impact of family history of colorectal cancer on age-specific prevalence of colorectal Seulki Kim
(Seoul)
14:40-14:50 The association of cigarette smoking and alcohol consumption with sessile serrated adenoma in 30-49 year-old subjects Ji Young Lee
(Seoul)
14:50-15:00 prevalence of and risk factors for colorectal neoplasia in asymptomatic young adults aged 20 to 39 years Jin Ju Song
(Seoul)
15:00-15:10 Does colon diverticulosis raise the risk of adenomatous colon polyp in patients with colorectal cancer? Suyun Oh
(Suwon)
Symposium GI-05 (LG)
Nov. 16 (Fri)
16:00-17:30
The cutting edge issues in management of IBD 2018 102 (1F)
Chairperson(s) Suk-Kyun Yang (Seoul), Jiaming Qian (Beijing)
16:00-16:20 What should be the therapeutic targets in IBD therapy? Siew Chien Ng
(Hong Kong)
16:20-16:40 Proper positioning of various drugs in therapeutic algorithm Won Moon
(Busan)
16:40-17:00 Place of TDM in optimal use of biologics Akira Andoh
(Otsu)
17:00-17:20 Managing Crohn's disease after surgery Kang-Moon Lee
(Suwon)
17:20-17:30 Q&As
Symposium GI-06 (UG)
Nov. 16 (Fri)
16:00-17:30
All about GIST on UGI tract 202 (2F)
Chairperson(s) Chang-Hun Yang (Gyeongju), Byung-Wook Kim (Incheon)
16:00-16:20 Pathologic diagnosis; focused on prognostic factor Gu Hyun Kang
(Seoul)
16:20-16:40 Endoscopic treatment: when and how? Hanglak Lee
(Seoul)
16:40-17:00 Surgical treatment: when and how? Hyundong Chae
(Daegu)
17:00-17:20 Target therapy: when and how? Dong-Hoe Koo
(Seoul)
17:20-17:30 Q&As
PG Course-LG (Korean)
Nov. 16 (Fri)
16:00-17:30
Current status and future perspectives in management of small bowel diseases E1+2 (3F)
Chairperson(s) Hyun Soo Kim (Gwangju), Sung-Ae Jung (Seoul)
16:00-16:20 Optimal approach to small bowel bleeding Hyun Jung Lee
(Seoul)
16:20-16:40 Radiologic diagnosis of small bowel diseases Jeong Kyong Lee
(Seoul)
16:40-17:00 Therapeutic role of enteroscopy Sung Noh Hong
(Seoul)
17:00-17:20 Interesting cases of various small bowel diseases Bong Min Ko
(Bucheon)
17:20-17:30 Q&As

Go to Top

Supported by
Member Societies
  • President : Dong Ki Lee
  • Business License No. 106-82-07189

Copyright© 2008 The Korean Society of Gastroenterlogy. All Rights Reserved.

Room 305, 31 Seolleung-ro 86 gil, Gangnam-gu, Seoul, 06193, Korea
Associated Societies
Secretariat